In 2019, the field of personalized medicine continued to grow with the market launch of more than two dozen drugs targeting novel genomic alterations and numerous genetic tests to determine whether patients are at risk for serious diseases like cancer, and whether they are likely to respond to therapy.Read More
Ellen T. Matloff, President and CEO of My Gene Counsel, breaks down the controversy surrounding the recent 60 Minutes episode on Preimplantation Genetic Diagnosis (PGD). Listen to find out what PGD means, how it’s used and why its purpose is often misinterpreted.
One genetic testing company recently grabbed headlines by announcing that for just $249 they will be offering a cancer gene panel that will test for 19 hereditary cancer genes. There is no doubt that low-cost options like these will break access to genetic testing wide open.
Cancer Bytes: By Ellen Matloff
Welcome to Cancer Bytes, featuring interviews with people touched by cancer. We hope that by listening to stories from cancer survivors we can help you through your process of healing and coping with the disease.